Meitheal Pharmaceuticals Releases Propofol Injectable Emulsion

Meitheal Pharmaceuticals is expanding accessibility for essential anesthetic treatments with the release of the new propofol injectable emulsion, USP. This release is currently available in 3 different dosage options to support diverse clinical needs: 200 mg, 500 mg, and 1000 mg single dose vials.^1,2

Propofol is an intravenous and short-acting anesthetic meant to assist in inducing and maintaining general anesthesia along with providing sedation for patients in intensive care unit (ICU) settings or undergoing surgical procedures.^3,4 Propofol has rapid onset, which allows health professionals to quickly induce anesthesia, and short duration that wears off after injection and/or infusion is stopped, making it beneficial for both short and long procedures as well as for controlling sedation as needed for patients in ICU.^3,4

The new launch provides more flexibility and accessibility for clinicians to use the exact amount of propofol needed without wasting medication due the vial sizes.^1,2 Pharmacists can measure and prepare doses with a higher accuracy by providing medication in these exact amounts which can reduce the chances of dosing errors and ensure that less medication goes to waste.² These consistent vial sizes and clear packaging can help pharmacists stay on top of inventory management, plan ahead for all sorts of different patient needs, and ensure that surgical and ICU units remain stocked. These features allow pharmacists to work more efficiently, maintain safety standards, and support smooth operations in surgical and critical care settings.

“At Meitheal, we remain dedicated to delivering high-quality, affordable medications that support better outcomes for patients and providers,” the company said in an announcement.¹

References

1. Meitheal Pharmaceuticals. Meitheal Pharmaceuticals is pleased to announce the launch of Propofol Injectable Emulsion, USP [LinkedIn post]. LinkedIn. Published April 7, 2026. Accessed April 7, 2026. https://www.linkedin.com/posts/meitheal-pharmaceuticals-is-pleased-to-announce-ugcPost-7447299822178545664-XrjI/

2. Meitheal Pharmaceuticals. Propofol Injectable Emulsion, USP. Accessed April 7, 2026. https://www.meithealpharma.com/our-products/89

3. US National Library of Medicine. Propofol injectable emulsion, USP (Meitheal Pharmaceuticals) prescribing information. DailyMed. Updated December 12, 2025. Accessed April 7, 2026. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=548d5192-2e5e-4c1b-8f17-940b6e791ae5

4. Folino TB, Muco E, Safadi AO, Parks LJ. Propofol. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2023. Accessed April 7, 2026. https://www.ncbi.nlm.nih.gov/books/NBK430884/